1-2 of 2
Ana Triguero
Close
Sort by
Journal Articles

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

Francesca Guijarro, Monica López-Guerra, Jordi Morata, Alex Bataller, Sara Paz, Josep Maria Cornet-Masana, Antònia Banús-Mulet, Laia Cuesta-Casanovas, Josep Maria Carbó, Sandra Castaño-Díez, Carlos Jiménez-Vicente, Albert Cortés-Bullich, Ana Triguero, Alexandra Martínez-Roca, Daniel Esteban, Marta Gómez-Hernando, José Ramón Álamo Moreno, Irene López-Oreja, Marta Garrote, Ruth M. Risueño, Raúl Tonda, Ivo Gut, Dolors Colomer, Marina Díaz-Beya, Jordi Esteve
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5799–5811.
https://doi.org/10.1182/bloodadvances.2023009742
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study

Clinical Trials & Observations
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larràn, Bjorn Andreasson, Alessandro M. Vannucchi, Tiziano Barbui
Journal: Blood Advances
Blood Adv (2022) 6 (2): 373–375.
https://doi.org/10.1182/bloodadvances.2021006006
Published: 2022
Includes: Supplemental data